BioAtla, Inc. (BCAB)
1.71
+0.48
(+39.02%)
USD |
OTCM |
Oct 23, 16:00
BioAtla EPS Diluted (Quarterly) : 0.272 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.272 |
| March 31, 2026 | -4.224 |
| December 31, 2025 | -8.181 |
| September 30, 2025 | -13.43 |
| June 30, 2025 | -15.99 |
| March 31, 2025 | -0.2632 |
| December 31, 2024 | -14.90 |
| September 30, 2024 | -0.219 |
| June 30, 2024 | -0.437 |
| March 31, 2024 | -0.4832 |
| December 31, 2023 | -0.5606 |
| September 30, 2023 | -0.6967 |
| June 30, 2023 | -0.7494 |
| March 31, 2023 | -0.5772 |
| Date | Value |
|---|---|
| December 31, 2022 | -0.6259 |
| September 30, 2022 | -0.6871 |
| June 30, 2022 | -0.7725 |
| March 31, 2022 | -0.6498 |
| December 31, 2021 | -0.6272 |
| September 30, 2021 | -0.6762 |
| June 30, 2021 | -0.9021 |
| March 31, 2021 | -0.5555 |
| December 31, 2020 | -0.487 |
| September 30, 2020 | -0.3455 |
| June 30, 2020 | -0.1848 |
| March 31, 2020 | -0.0476 |
| December 31, 2019 | -0.0882 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | -1.355 |
| Oncolytics Biotech, Inc. | -0.0788 |
| Sangamo Therapeutics, Inc. | -0.0796 |
| Sarepta Therapeutics, Inc. | -0.0464 |
| Anixa Biosciences, Inc. | -0.0762 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 0.452M |
| Revenue (Quarterly) | 6.50M |
| Total Expenses (Quarterly) | 6.048M |
| Enterprise Value | 7.163M |
| Profit Margin (Quarterly) | 6.95% |
| Earnings Yield | -1.49K% |
| Normalized Earnings Yield | -1507.75 |